fatnews.com Fatnews Bitchute Channel Link Home page  >  Article | Previous article | Next article



  • Categories of Articles
  • Summary View
  • Headline View
  • Archive of Quotes
  • Contact Us
  • Belviq (lorcaserin) increases risk of mitral regurgitation 2-fold

    Posted by .(JavaScript must be enabled to view this email address)
    Saturday, November 01, 2014 12:34 pm Email this article

    Belviq (lorcaserin), a weight loss drug, was associated with a 2-fold increased risk of moderate or greater mitral regurgitation after one-year of drug use according to a paper looking at side effects of the drug written by James DiNicolantonio, PharmD and others.

    “Despite the fact that the lorcaserin package insert states that it does not cause a significant increase in FDA-defined valvulopathy, defined as mitral regurgitation greater than mild or aortic regurgitation greater than trace (pooled relative risk (RR) of the phase 3 echocardiographic data: 1.16; 95% CI 0.81 to 1.67), a look at the FDA Medical Review states that lorcaserin causes a significant increase in moderate or greater mitral regurgitation at week 52 (RR 1.95; 95% CI 1.05 to 3.59, p value not stated) and (RR 1.88; 95% CI 1.02 to 3.47, p=0.04) based on our forest plot) (figure 1),” the paper notes.

    “These data were based on a meta-analysis of three randomised controlled trials testing lorcaserin 10 mg twice daily versus placebo.”


    DiNicolantonio JJ, Chatterjee S, O’Keefe JH, and Meier P. Lorcaserin for the treatment of obesity? A closer look at its side effects. Open Heart, 2014; 1(1): http://openheart.bmj.com/content/1/1/e000173.full.

    Author’s Contact Info

    James J. DiNicolantonio, PharmD
    Associate Editor BMJ Open Heart
    Cardiovascular Research Scientist
    Saint Luke’s Mid America Heart Institute
    .(JavaScript must be enabled to view this email address)

    Articles on the same subject can be found here:


    Please feel free to share your comments about this article.




    Please enter the word you see in the image below:

    Remember my personal information

    Notify me of follow-up comments?

    © Copyright 2003-2021 - Larry Hobbs - All Rights Reserved.